30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Control of lupus nephritis by changes of gut microbiota

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Systemic lupus erythematosus, characterized by persistent inflammation, is a complex autoimmune disorder with no known cure. Immunosuppressants used in treatment put patients at a higher risk of infections. New knowledge of disease modulators, such as symbiotic bacteria, can enable fine-tuning of parts of the immune system, rather than suppressing it altogether.

          Results

          Dysbiosis of gut microbiota promotes autoimmune disorders that damage extraintestinal organs. Here we report a role of gut microbiota in the pathogenesis of renal dysfunction in lupus. Using a classical model of lupus nephritis, MRL/ lpr, we found a marked depletion of Lactobacillales in the gut microbiota. Increasing Lactobacillales in the gut improved renal function of these mice and prolonged their survival. We used a mixture of 5 Lactobacillus strains ( Lactobacillus oris, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus johnsonii, and Lactobacillus gasseri), but L. reuteri and an uncultured Lactobacillus sp. accounted for most of the observed effects. Further studies revealed that MRL/ lpr mice possessed a “leaky” gut, which was reversed by increased Lactobacillus colonization. Lactobacillus treatment contributed to an anti-inflammatory environment by decreasing IL-6 and increasing IL-10 production in the gut. In the circulation, Lactobacillus treatment increased IL-10 and decreased IgG2a that is considered to be a major immune deposit in the kidney of MRL/ lpr mice. Inside the kidney, Lactobacillus treatment also skewed the Treg-Th17 balance towards a Treg phenotype. These beneficial effects were present in female and castrated male mice, but not in intact males, suggesting that the gut microbiota controls lupus nephritis in a sex hormone-dependent manner.

          Conclusions

          This work demonstrates essential mechanisms on how changes of the gut microbiota regulate lupus-associated immune responses in mice. Future studies are warranted to determine if these results can be replicated in human subjects.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s40168-017-0300-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: not found

          Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults

          Background Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. Methods and Findings The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). Conclusions The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

            IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease. We show here that the orphan nuclear receptor RORgammat is the key transcription factor that orchestrates the differentiation of this effector cell lineage. RORgammat induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naïve CD4(+) T helper cells and is required for their expression in response to IL-6 and TGF-beta, the cytokines known to induce IL-17. Th17 cells are constitutively present throughout the intestinal lamina propria, express RORgammat, and are absent in mice deficient for RORgammat or IL-6. Mice with RORgammat-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells. Together, these studies suggest that RORgammat is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Systemic lupus erythematosus.

                Bookmark

                Author and article information

                Contributors
                qhmu@vt.edu
                husen.zhang@nih.gov
                xifeli@vt.edu
                kaisen6@vt.edu
                hualanliu@lbl.gov
                mredward@vt.edu
                ansrahmd@vt.edu
                rxyuan@vt.edu
                lwli@vt.edu
                tcecere@vt.edu
                bdavid2@vt.edu
                jayk14@vt.edu
                poorna08@vt.edu
                cmcphee@vt.edu
                kread@vtc.vt.edu
                oestrk@vtc.vt.edu
                mvieson@vt.edu
                chreilly@vcom.vt.edu
                xinluo@vt.edu
                Journal
                Microbiome
                Microbiome
                Microbiome
                BioMed Central (London )
                2049-2618
                11 July 2017
                11 July 2017
                2017
                : 5
                : 73
                Affiliations
                [1 ]ISNI 0000 0001 2178 7701, GRID grid.470073.7, Department of Biomedical Sciences and Pathobiology, , Virginia-Maryland College of Veterinary Medicine, Virginia Tech, ; Blacksburg, VA USA
                [2 ]ISNI 0000 0001 0694 4940, GRID grid.438526.e, Department of Civil and Environmental Engineering, , Virginia Tech, ; Blacksburg, VA USA
                [3 ]ISNI 0000 0001 0694 4940, GRID grid.438526.e, Department of Biological Sciences, , Virginia Tech, ; Blacksburg, VA USA
                [4 ]ISNI 0000 0001 0694 4940, GRID grid.438526.e, Department of Animal and Poultry Sciences, , Virginia Tech, ; Blacksburg, VA USA
                [5 ]ISNI 0000 0001 0694 4940, GRID grid.438526.e, , Virginia Tech Carilion Research Institute and School of Medicine, ; Roanoke, VA USA
                [6 ]ISNI 0000 0000 8550 1509, GRID grid.418737.e, , Edward Via College of Osteopathic Medicine, ; Blacksburg, VA USA
                [7 ]ISNI 0000 0004 0483 9129, GRID grid.417768.b, Present Address: Cancer and Inflammation Program, , Center for Cancer Research, National Cancer Institute, ; Bethesda, MD 20892 USA
                [8 ]ISNI 0000 0001 2231 4551, GRID grid.184769.5, , Present Address: Lawrence Berkeley National Laboratory, ; Berkeley, CA 94720 USA
                Article
                300
                10.1186/s40168-017-0300-8
                5505136
                28697806
                142c1ecb-e778-4240-939a-ac3f1954057c
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 21 October 2016
                : 5 July 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: R03-AI117597
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                gut microbiota,lupus,leaky gut,autoimmunity
                gut microbiota, lupus, leaky gut, autoimmunity

                Comments

                Comment on this article